Prudential Financial, Inc. to Announce First Quarter 2024 Earnings; Schedules Conference Call
NEWARK, N.J.–(BUSINESS WIRE)–Prudential Financial, Inc. (NYSE: PRU) will release its first quarter 2024 earnings on Tuesday, April 30, 2024, after the... Read more.
ITT Nominates Christopher O’Shea for Election to Board of Directors
STAMFORD, Conn.–(BUSINESS WIRE)–April 2, 2024– ITT Inc. (NYSE: ITT) today announced the nomination of Christopher O’Shea for election to its... Read more.
Colohouse Acquires Hivelocity to Create Next-Generation Service Provider
The Acquisition of Hivelocity elevates the company’s service offerings, addressing customer demand with enhanced automation capabilities TAMPA, Fla.–(BUSINESS... Read more.
Global and China Automotive Functional Safety and Safety Of The Intended Functionality (SOTIF) Research Report 2024 Featuring Layout of 10 Major OEMs and Solutions for 12 Main Enterprises – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global and China Automotive Functional Safety and Safety Of The Intended Functionality (SOTIF) Research Report, 2024”... Read more.
Charles River Associates (CRA) Strengthens its Antitrust & Competition Economics Practice in Canada
BOSTON–(BUSINESS WIRE)–Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services,... Read more.
New CyberArk Managed Service Provider Console Makes It Easy for MSPs to Offer Identity Security Services at Scale
Unified Interface Means MSPs Can Seamlessly View, Monitor and Administer All MSP-Controlled CyberArk Customer Environments from a Single Place NEWTON, Mass. &... Read more.
CHX STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of ChampionX Corporation Is Fair to Shareholders
NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of ChampionX Corporation (NASDAQ: CHX) to SLB... Read more.
Kiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical Trial
Trial’s Safety Monitoring Committee Recommends Maintaining Initial Cell Dose Level for Next Cohort of Patients HOUSTON–(BUSINESS WIRE)–$KRBP #GDT—Kiromic... Read more.
Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing
MELT-300 Pivotal Phase 3 Program Topline Readout Expected in Q4 2024 NASHVILLE, Tenn.–(BUSINESS WIRE)–Melt Pharmaceuticals, Inc. (“Melt”), a clinical‑stage... Read more.
Global and China L3/L4 Autonomous Driving and Startups Research Report 2024 Featuring Solutions of 15 OEMs and 21 Solutions of Tier1s and Startups – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “L3/L4 Autonomous Driving and Startups Research Report, 2024” report has been added to ResearchAndMarkets.com’s... Read more.